Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Manufacturing
After a pause, Aurobindo resumes drug shipments from India plant
Aurobindo’s Eugia Pharma division has resumed shipping drugs from a plant in India that had to pause production in the wake of an FDA inspection.
Joseph Keenan
Mar 13, 2024 3:40pm
Despite solid pharma growth, Merck KGaA sees total sales decline
Mar 7, 2024 3:32pm
Catalent cites impairment charge for quarterly earnings delay
Nov 14, 2023 9:55am
Takeda takes $770M in write-downs amid Alofisel, Exkivity woes
Oct 26, 2023 12:27pm
Strides to spin off its CDMO and soft gelatin businesses
Sep 25, 2023 10:05am
In long-awaited report, Catalent delivers slight revenue tweak
Jun 12, 2023 2:05pm